市场调查报告书
商品编码
1327586
经导管二尖瓣瓣膜修復术市场(金额,数量,ASP):各市场区隔规模,占有率,趋势及SWOT分析,法律规章及偿付趋势,手术,2033年前的预测Transcatheter Mitral Valve Repair Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
经导管二尖瓣修復术现已获得 FDA 批准,用于非手术、高风险的退行性二尖瓣反流。对于有适应症的患者,二尖瓣成形术是优于二尖瓣置换术的首选治疗方法,因为其短期和长期死亡率和发病率较低。由于年龄或其他医疗状况,大约 50% 的严重二尖瓣反流患者不适合手术。经导管二尖瓣成形术(TMVR)用于二尖瓣反流(MR)的微创治疗。
本报告提供全球经导管二尖瓣瓣膜修復术市场相关之详细考察,提供市场上竞争情形,SWOT分析,到2033年前的市场预测,COVID-19影响,地区,各国趋势等资讯。
Transcatheter Mitral Valve Repair Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Repair market for the year 2020 and beyond. Transcatheter Mitral Valve Repair is currently FDA approved for non-surgical high risk degenerative mitral regurgitation. Mitral valve repair treatment is preferred over mitral valve replacement in patients who are eligible because it is linked with a lower short term and long term mortality and morbidity rates. Approximately, 50% of the severe mitral regurgitation patients are not eligible for surgery due to their age or other disorders. Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR).
Each of the covered 25 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Japan, Australia, Canada, Mexico, Denmark, Ireland, Netherlands, New Zealand, Sweden, Switzerland, Austria, Belgium, Finland, Norway, Poland, and Portugal.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -